NLRP3 deficiency accelerates pressure overload-induced cardiac remodeling via increased TLR4 expression

The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation

(2018) Gonzalo J. Martínez et al.   ATHEROSCLEROSIS

NLRP3: A promising therapeutic target for autoimmune diseases

(2018) Hui-Hui Shen et al.   AUTOIMMUNITY REVIEWS

Aucubin protects against pressure overload-induced cardiac remodelling via the β3 -adrenoceptor-neuronal NOS cascades

(2018) Qing-Qing Wu et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure

(2018) Ling Zhou et al.   CIRCULATION

Molecular and clinical roles of incretin-based drugs in patients with heart failure

(2018) Bassant Orabi et al.   HEART FAILURE REVIEWS

Inhibition of myocardial hypertrophy by magnesium isoglycyrrhizinate through the TLR4/NF-κB signaling pathway in mice

(2018) Donglai Ma et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

NLRP3 as a potentially novel biomarker for the management of osteoarthritis

(2018) M.J. McAllister et al.   OSTEOARTHRITIS AND CARTILAGE

Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns

(2018) Luis E. Pavillard et al.   PHARMACOLOGICAL RESEARCH

Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications

(2018) Arpeeta Sharma et al.   Frontiers in Physiology

Intermedin1–53 Protects Cardiac Fibroblasts by Inhibiting NLRP3 Inflammasome Activation During Sepsis

(2017) Di Wu et al.   INFLAMMATION

The NLRP3 inflammasome in acute myocardial infarction

(2017) Stefano Toldo et al.   Nature Reviews Cardiology

NLRP3-inflammasome inhibition prevents high fat and high sugar diets-induced heart damage through autophagy induction

(2017) Luís E. Pavillard et al.   Oncotarget

Andrographolide Protects against Aortic Banding-Induced Experimental Cardiac Hypertrophy by Inhibiting MAPKs Signaling

(2017) Qing Q. Wu et al.   Frontiers in Pharmacology

How cardiomyocytes sense pathophysiological stresses for cardiac remodeling

(2016) Zaffar K. Haque et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

The role of Toll-like receptor 4 (TLR4) in cardiac ischaemic-reperfusion injury, cardioprotection and preconditioning

(2016) Sam Man Lee et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

OX40 regulates pressure overload-induced cardiac hypertrophy and remodelling via CD4+ T-cells

(2016) Q.-Q. Wu et al.   CLINICAL SCIENCE

Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs)

(2016) Neil A. Turner   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

The emerging role of Toll-like receptor 4 in myocardial inflammation

(2016) Y Yang et al.   Cell Death & Disease

Cathepsin B deficiency attenuates cardiac remodeling in response to pressure overload via TNF-α/ASK1/JNK pathway

(2015) Qing-Qing Wu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Novel Role for Caspase-Activated DNase in the Regulation of Pathological Cardiac Hypertrophy

(2015) L. Gao et al.   HYPERTENSION

The NLRP3 Inflammasome and Diabetic Cardiomyopathy

(2013) Lalit P. Singh   CARDIOVASCULAR DRUGS AND THERAPY